These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26550933)

  • 1. Comments on the opinions published by Bergman et al. (2015) on Critical Comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals (Lamb et al., 2014).
    Lamb JC; Boffetta P; Foster WG; Goodman JE; Hentz KL; Rhomberg LR; Staveley J; Swaen G; Van Der Kraak G; Williams AL
    Regul Toxicol Pharmacol; 2015 Dec; 73(3):754-7. PubMed ID: 26550933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manufacturing doubt about endocrine disrupter science--A rebuttal of industry-sponsored critical comments on the UNEP/WHO report "State of the Science of Endocrine Disrupting Chemicals 2012".
    Bergman Å; Becher G; Blumberg B; Bjerregaard P; Bornman R; Brandt I; Casey SC; Frouin H; Giudice LC; Heindel JJ; Iguchi T; Jobling S; Kidd KA; Kortenkamp A; Lind PM; Muir D; Ochieng R; Ropstad E; Ross PS; Skakkebaek NE; Toppari J; Vandenberg LN; Woodruff TJ; Zoeller RT
    Regul Toxicol Pharmacol; 2015 Dec; 73(3):1007-17. PubMed ID: 26239693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals - 2012.
    Lamb JC; Boffetta P; Foster WG; Goodman JE; Hentz KL; Rhomberg LR; Staveley J; Swaen G; Van Der Kraak G; Williams AL
    Regul Toxicol Pharmacol; 2014 Jun; 69(1):22-40. PubMed ID: 24530840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals.
    Vandenberg LN; Ågerstrand M; Beronius A; Beausoleil C; Bergman Å; Bero LA; Bornehag CG; Boyer CS; Cooper GS; Cotgreave I; Gee D; Grandjean P; Guyton KZ; Hass U; Heindel JJ; Jobling S; Kidd KA; Kortenkamp A; Macleod MR; Martin OV; Norinder U; Scheringer M; Thayer KA; Toppari J; Whaley P; Woodruff TJ; Rudén C
    Environ Health; 2016 Jul; 15(1):74. PubMed ID: 27412149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight of evidence approaches for the identification of endocrine disrupting properties of chemicals: Review and recommendations for EU regulatory application.
    Gross M; Green RM; Weltje L; Wheeler JR
    Regul Toxicol Pharmacol; 2017 Dec; 91():20-28. PubMed ID: 28986177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Issue analysis: key characteristics approach for identifying endocrine disruptors.
    Borgert CJ
    Arch Toxicol; 2023 Oct; 97(10):2819-2822. PubMed ID: 37572129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodological issues in human studies of endocrine disrupting chemicals.
    Lee DH; Jacobs DR
    Rev Endocr Metab Disord; 2015 Dec; 16(4):289-97. PubMed ID: 26880303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ECETOC Florence workshop on risk assessment of endocrine substances, including the potency concept.
    Fegert I
    Toxicol Lett; 2013 Dec; 223(3):310-4. PubMed ID: 23558296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk assessment of endocrine active chemicals: identifying chemicals of regulatory concern.
    Bars R; Fegert I; Gross M; Lewis D; Weltje L; Weyers A; Wheeler JR; Galay-Burgos M
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):143-54. PubMed ID: 22735369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk assessment of 'endocrine substances': guidance on identifying endocrine disruptors.
    Lewis RW
    Toxicol Lett; 2013 Dec; 223(3):287-90. PubMed ID: 24036001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovation in regulatory approaches for endocrine disrupting chemicals: The journey to risk assessment modernization in Canada.
    Barton-Maclaren TS; Wade M; Basu N; Bayen S; Grundy J; Marlatt V; Moore R; Parent L; Parrott J; Grigorova P; Pinsonnault-Cooper J; Langlois VS
    Environ Res; 2022 Mar; 204(Pt C):112225. PubMed ID: 34666016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tributyltin: Advancing the Science on Assessing Endocrine Disruption with an Unconventional Endocrine-Disrupting Compound.
    Lagadic L; Katsiadaki I; Biever R; Guiney PD; Karouna-Renier N; Schwarz T; Meador JP
    Rev Environ Contam Toxicol; 2018; 245():65-127. PubMed ID: 29119384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine disrupting chemicals: strategies to protect present and future generations.
    Vandenberg LN
    Expert Rev Endocrinol Metab; 2021 May; 16(3):135-146. PubMed ID: 33973826
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing dose-response relationships for endocrine disrupting chemicals (EDCs): a focus on non-monotonicity.
    Zoeller RT; Vandenberg LN
    Environ Health; 2015 May; 14():42. PubMed ID: 25971795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why endocrine disrupting chemicals (EDCs) challenge traditional risk assessment and how to respond.
    Futran Fuhrman V; Tal A; Arnon S
    J Hazard Mater; 2015 Apr; 286():589-611. PubMed ID: 25646754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A path forward in the debate over health impacts of endocrine disrupting chemicals.
    Zoeller RT; Bergman Å; Becher G; Bjerregaard P; Bornman R; Brandt I; Iguchi T; Jobling S; Kidd KA; Kortenkamp A; Skakkebaek NE; Toppari J; Vandenberg LN
    Environ Health; 2014 Dec; 13():118. PubMed ID: 25533907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory effects of environmental endocrine disrupting chemicals.
    Kuo CH; Yang SN; Kuo PL; Hung CH
    Kaohsiung J Med Sci; 2012 Jul; 28(7 Suppl):S37-42. PubMed ID: 22871600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DEDuCT 2.0: An updated knowledgebase and an exploration of the current regulations and guidelines from the perspective of endocrine disrupting chemicals.
    Karthikeyan BS; Ravichandran J; Aparna SR; Samal A
    Chemosphere; 2021 Mar; 267():128898. PubMed ID: 33190914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental effect assessment for sexual endocrine-disrupting chemicals: Fish testing strategy.
    Knacker T; Boettcher M; Frische T; Rufli H; Stolzenberg HC; Teigeler M; Zok S; Braunbeck T; Schäfers C
    Integr Environ Assess Manag; 2010 Oct; 6(4):653-62. PubMed ID: 20872646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Daphnia magna reproduction test for detecting endocrine disruptors.
    Dang Z; Cheng Y; Chen HM; Cui Y; Yin HH; Traas T; Montforts M; Vermeire T
    Chemosphere; 2012 Jul; 88(4):514-23. PubMed ID: 22469199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.